Inspire Medical Systems (INSP) Competitors $187.77 +2.35 (+1.27%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends INSP vs. ZBH, SOLV, SNN, PEN, GKOS, BLCO, PRCT, AXNX, NVCR, and NVSTShould you be buying Inspire Medical Systems stock or one of its competitors? The main competitors of Inspire Medical Systems include Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Glaukos (GKOS), Bausch + Lomb (BLCO), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), and Envista (NVST). These companies are all part of the "medical equipment" industry. Inspire Medical Systems vs. Zimmer Biomet Solventum Smith & Nephew Penumbra Glaukos Bausch + Lomb PROCEPT BioRobotics Axonics NovoCure Envista Zimmer Biomet (NYSE:ZBH) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends. Does the MarketBeat Community prefer ZBH or INSP? Zimmer Biomet received 713 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 67.16% of users gave Zimmer Biomet an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformZimmer BiometOutperform Votes90067.16% Underperform Votes44032.84% Inspire Medical SystemsOutperform Votes18761.31% Underperform Votes11838.69% Does the media prefer ZBH or INSP? In the previous week, Zimmer Biomet had 9 more articles in the media than Inspire Medical Systems. MarketBeat recorded 17 mentions for Zimmer Biomet and 8 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.63 beat Zimmer Biomet's score of 0.84 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 6 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Inspire Medical Systems 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has stronger earnings & valuation, ZBH or INSP? Zimmer Biomet has higher revenue and earnings than Inspire Medical Systems. Zimmer Biomet is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimmer Biomet$7.60B2.81$1.02B$5.2620.37Inspire Medical Systems$755.59M7.45-$21.15M$1.07175.49 Do analysts rate ZBH or INSP? Zimmer Biomet presently has a consensus target price of $123.33, indicating a potential upside of 15.14%. Inspire Medical Systems has a consensus target price of $233.58, indicating a potential upside of 24.40%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Zimmer Biomet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 2 Sell rating(s) 11 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.25Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders and institutionals believe in ZBH or INSP? 88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 1.0% of Zimmer Biomet shares are held by insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is ZBH or INSP more profitable? Zimmer Biomet has a net margin of 14.27% compared to Inspire Medical Systems' net margin of 4.37%. Zimmer Biomet's return on equity of 12.95% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Zimmer Biomet14.27% 12.95% 7.55% Inspire Medical Systems 4.37%5.30%4.58% Which has more risk & volatility, ZBH or INSP? Zimmer Biomet has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. SummaryZimmer Biomet and Inspire Medical Systems tied by winning 9 of the 18 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Inspire Medical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INSP vs. The Competition Export to ExcelMetricInspire Medical SystemsSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$5.63B$4.36B$5.02B$19.19BDividend YieldN/A41.45%4.87%3.57%P/E Ratio175.4925.01135.2041.24Price / Sales7.4545.671,120.3117.58Price / CashN/A43.4640.5821.28Price / Book9.687.364.755.32Net Income-$21.15M$13.64M$118.50M$989.67M7 Day Performance-0.10%-2.76%-1.83%-3.59%1 Month Performance1.57%0.38%12.27%-2.48%1 Year Performance1.66%44.25%31.72%13.87% Inspire Medical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INSPInspire Medical Systems4.6549 of 5 stars$187.77+1.3%$233.58+24.4%+1.7%$5.56B$755.59M175.491,011Positive NewsZBHZimmer Biomet4.7285 of 5 stars$108.33+1.5%$122.83+13.4%-10.7%$21.57B$7.60B20.6818,000Dividend AnnouncementAnalyst UpgradeSOLVSolventum1.307 of 5 stars$69.73+0.2%$68.29-2.1%N/A$12.05BN/A0.0022,000Positive NewsSNNSmith & Nephew3.6992 of 5 stars$25.50-0.1%N/A-7.3%$11.15B$5.55B13.0318,452News CoveragePENPenumbra4.2288 of 5 stars$248.37+1.1%$252.42+1.6%-1.8%$9.53B$1.16B285.524,200Analyst ForecastGKOSGlaukos4.1076 of 5 stars$143.87+3.6%$143.17-0.5%+89.5%$7.93B$360.35M-46.00780Analyst ForecastShort Interest ↓BLCOBausch + Lomb3.0993 of 5 stars$18.62+0.1%$20.58+10.5%+16.9%$6.56B$4.68B-17.7113,300PRCTPROCEPT BioRobotics2.7844 of 5 stars$89.54+0.3%$97.86+9.3%+102.9%$4.67B$136.19M0.00626Positive NewsAXNXAxonics1.4327 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.7422 of 5 stars$32.84-1.7%$32.67-0.5%+138.4%$3.55B$577.74M-23.861,453NVSTEnvista3.9012 of 5 stars$19.59+0.6%$20.65+5.4%-21.1%$3.37B$2.50B-2.5112,800 Related Companies and Tools Related Companies Zimmer Biomet Alternatives Solventum Alternatives Smith & Nephew Alternatives Penumbra Alternatives Glaukos Alternatives Bausch + Lomb Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives NovoCure Alternatives Envista Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:INSP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
